| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 1,921 | 2,103 | 2,067 | 2,083 | 2,249 | 2,336 | 2,320 | 2,674 | 2,526 | 2,374 | 2,454 | 2,708 | 2,744 |
| Expenses | 1,470 | 1,586 | 1,617 | 1,468 | 1,516 | 1,579 | 1,526 | 1,775 | 1,616 | 1,558 | 1,541 | 1,616 | 1,686 |
| EBITDA | 450 | 517 | 450 | 615 | 733 | 757 | 793 | 898 | 910 | 816 | 913 | 1,092 | 1,058 |
| Operating Profit % | 21 % | 21 % | 18 % | 25 % | 27 % | 27 % | 32 % | 32 % | 33 % | 29 % | 32 % | 36 % | 34 % |
| Depreciation | 131 | 124 | 63 | 66 | 71 | 103 | 109 | 115 | 106 | 62 | 61 | 58 | 58 |
| Interest | 1 | 1 | 1 | 0 | 1 | 11 | 15 | 11 | 13 | 15 | 8 | 10 | 8 |
| Profit Before Tax | 238 | 402 | 517 | 548 | 660 | 643 | 669 | 773 | 824 | 746 | 1,016 | 976 | 993 |
| Tax | 138 | 179 | 180 | 188 | 231 | 133 | 171 | 160 | 200 | 195 | 249 | 253 | 261 |
| Net Profit | 100 | 223 | 337 | 360 | 429 | 509 | 498 | 613 | 624 | 551 | 768 | 722 | 735 |
| EPS in ₹ | 15.26 | 66.66 | 73.61 | 78.70 | 93.78 | 111.28 | 108.77 | 133.89 | 136.38 | 119.22 | 167.79 | 157.92 | 160.70 |
Pfizer
Pfizer
4,823.90
+22.60
(0.47%)
Market Cap
22,068.25 Cr
PE Ratio
29.86
Volume
26,661.00
Day High - Low
4,848.10 - 4,780.00
52W High-Low
5,873.50 - 4,360.10
Q1 Quarterly Results are out. Check out the updated financials1 day ago
View
Key Fundamentals
Market Cap
22,068.25 Cr
EPS
157.92
PE Ratio
29.86
PB Ratio
5.22
Book Value
918.71
EBITDA
1,092.00
Dividend Yield
1.56 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
17.19
Debt to Equity
0.02
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Pfizer Limited concluded its 75th AGM on July 28, 2026, approving a ₹75 dividend per share for FY26. The meeting also saw the re-appointment of P. Rengan as a director and ratification of cost auditor fees.
Pfizer Q1 Results: Revenue rises to ₹6.5B YoY3 days ago
Pfizer reports Q1 revenue of ₹6.5B rupees vs ₹6B YoY, EBITDA at ₹2.47B with margin expanding to 37.9%, and net profit at ₹2.04B vs ₹1.9B YoY.
Pfizer CFO Amit Agarwal resigns Oct 8
4 days ago
4 days agoPfizer Limited discloses that CFO Amit Agarwal will resign as Executive Director and Board member on October 8, 2026, to pursue an external opportunity.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,990.50 | #1 4,77,587.63 | 41.71 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 66.37 | |
8,056.00 | 2,13,861.49 | 81.06 | 11,067.00 | 13.95 | 2,568 | 13.44 | 82.30 | |
5,122.80 | 1,94,854.84 | 86.65 | 13,886.20 | 20.34 | 2,138 | 3.28 | 64.10 | |
1,473.20 | 1,19,011.77 | 35.29 | 29,044.60 | 2.24 | 3,870 | -39.18 | 61.43 | |
1,126.80 | 1,13,382.45 | 21.72 | 27,657.90 | 17.64 | 5,026 | 7.82 | 53.10 | |
2,415.00 | 1,10,421.66 | #1 20.65 | 29,038.90 | #1 26.75 | 5,356 | 87.72 | 49.50 | |
2,469.60 | 1,01,993.49 | 51.48 | 14,636.40 | 14.85 | 1,938 | 29.13 | 44.89 | |
1,816.20 | 98,048.75 | 88.28 | 6,867.80 | 22.01 | 890 | #1 123.93 | 81.68 | |
1,148.10 | 95,828.36 | 30.00 | 35,058.60 | 3.90 | 4,158 | -69.10 | 28.48 | |
1,580.20 | 90,921.21 | 26.12 | 33,384.70 | 3.21 | 3,376 | 1.99 | 57.35 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
10.35 %
Net Income Growth
-5.89 %
Cash Flow Change
46.66 %
ROE
-5.55 %
ROCE
-2.80 %
EBITDA Margin (Avg.)
8.44 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 2,612 | 2,914 | 3,261 | 3,690 | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 | 4,911 | 4,922 |
| Fixed Assets | 944 | 895 | 902 | 950 | 886 | 973 | 894 | 869 | 749 | 713 | 724 | 678 |
| Current Assets | 1,253 | 1,630 | 2,051 | 2,417 | 2,715 | 3,048 | 1,925 | 2,397 | 2,525 | 2,738 | 3,513 | 3,803 |
| Capital Work in Progress | 13 | 3 | 15 | 1 | 0 | 1 | 3 | 1 | 8 | 0 | 8 | 20 |
| Investments | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 1,655 | 2,011 | 2,343 | 2,739 | 3,054 | 3,432 | 2,369 | 3,030 | 3,244 | 3,516 | 4,180 | 4,224 |
| Total Equity & Liabilities | 2,612 | 2,914 | 3,261 | 3,690 | 3,940 | 4,405 | 3,266 | 3,901 | 4,001 | 4,229 | 4,911 | 4,922 |
| Current Liabilities | 606 | 759 | 780 | 954 | 892 | 873 | 774 | 853 | 657 | 547 | 570 | 628 |
| Non Current Liabilities | 32 | 36 | 62 | 52 | 37 | 137 | 99 | 183 | 136 | 87 | 124 | 92 |
| Total Equity | 1,973 | 2,118 | 2,419 | 2,683 | 3,011 | 3,396 | 2,393 | 2,864 | 3,207 | 3,596 | 4,217 | 4,203 |
| Reserve & Surplus | 1,927 | 2,072 | 2,373 | 2,637 | 2,966 | 3,350 | 2,347 | 2,819 | 3,162 | 3,550 | 4,172 | 4,157 |
| Share Capital | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 | 46 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | 181 | -417 | -4 | -17 | 23 | 1,690 | -1,613 | -88 | -26 | 75 | 383 | -392 |
| Investing Activities | 68 | -701 | -250 | -238 | 35 | 1,530 | -469 | -575 | -36 | 54 | -71 | -562 |
| Operating Activities | 114 | 346 | 329 | 332 | 98 | 323 | 427 | 667 | 356 | 257 | 660 | 968 |
| Financing Activities | -1 | -62 | -83 | -110 | -110 | -164 | -1,571 | -181 | -346 | -235 | -205 | -798 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % | 63.92 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 2.82 % | 0.00 % | 3.33 % | 3.22 % | 3.54 % | 2.75 % | 2.18 % | 2.39 % | 2.60 % | 2.71 % | 2.81 % | 1.65 % |
| DIIs | 13.08 % | 8.98 % | 8.98 % | 8.84 % | 8.57 % | 7.91 % | 14.85 % | 14.93 % | 14.89 % | 14.89 % | 15.01 % | 15.15 % | 15.33 % | 15.84 % | 16.03 % | 16.79 % | 17.10 % | 17.23 % | 17.10 % | 17.05 % | 16.89 % | 17.80 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 15.03 % | 14.11 % | 14.11 % | 14.25 % | 14.19 % | 14.08 % | 13.94 % | 13.71 % | 13.70 % | 13.69 % | 13.61 % | 13.21 % | 12.90 % | 12.55 % | 12.15 % | 12.12 % | 12.34 % | 12.02 % | 12.08 % | 11.93 % | 11.87 % | 12.04 % |
| Others | 7.97 % | 12.98 % | 12.98 % | 12.99 % | 13.32 % | 14.08 % | 7.29 % | 7.43 % | 7.49 % | 7.50 % | 4.64 % | 7.72 % | 4.52 % | 4.46 % | 4.35 % | 4.41 % | 4.45 % | 4.43 % | 4.29 % | 4.39 % | 4.51 % | 4.59 % |
| No of Share Holders | 1,45,980 | 1,21,153 | 1,21,153 | 1,26,808 | 1,25,287 | 1,23,449 | 1,22,028 | 1,17,950 | 1,17,194 | 1,15,988 | 1,16,948 | 1,12,456 | 1,09,214 | 1,06,098 | 98,824 | 1,05,015 | 1,08,261 | 1,03,222 | 1,03,480 | 1,00,933 | 99,545 | 1,02,478 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 20 | 20 | 22.5 | 330 | 35 | 35 | 40 | 35 | 165 | 75 |
| Dividend Yield (%) | 0.92 | 0.6 | 0.56 | 7.29 | 0.8 | 1 | 0.95 | 0.87 | 3.5 | 1.56 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 13 Aug 2021 |  Dividend | ₹ 30.00 /share | 11 Aug 2021 | 5,251.65 | 5,820.45 |
| 13 Aug 2021 | Dividend | ₹ 5.00 /share | 11 Aug 2021 | 5,251.65 | 5,820.45 |
| 19 Aug 2022 | Dividend | ₹ 35.00 /share | 18 Aug 2022 | 4,261.65 | 4,215.30 |
| 20 Feb 2022 | Dividend | ₹ 30.00 /share | 19 Sept 2022 | 4,277.45 | 4,346.40 |
| 11 Aug 2023 | Dividend | ₹ 5.00 /share | 11 Aug 2023 | 3,772.20 | 4,038.75 |
| 11 Aug 2023 | Dividend | ₹ 35.00 /share | 11 Aug 2023 | 3,772.20 | 4,038.75 |
| 21 Aug 2024 | Dividend | ₹ 35.00 /share | 21 Aug 2024 | 4,335.90 | 5,901.90 |
| 28 Aug 2024 |  Annual General Meeting | NA | 28 Aug 2024 | 5,842.95 | 5,862.80 |
| 28 Oct 2024 |  Quarterly Result Announcement | NA | 28 Oct 2024 | 5,673.00 | 5,308.70 |
| 31 Jan 2025 | Quarterly Result Announcement | NA | 31 Jan 2025 | 4,784.65 | 4,516.55 |
| 19 May 2025 | Quarterly Result Announcement | NA | 19 May 2025 | 4,249.90 | 4,411.35 |
| 09 Jul 2025 | Dividend | ₹ 35.00 /share | 09 Jul 2025 | 4,411.35 | 5,851.00 |
| 09 Jul 2025 | Dividend | ₹ 30.00 /share | 09 Jul 2025 | 4,411.35 | 5,851.00 |
| 21 Jul 2025 | Annual General Meeting | NA | 21 Jul 2025 | 4,411.35 | 5,319.50 |
| 13 Aug 2025 | Quarterly Result Announcement | NA | 13 Aug 2025 | 5,052.80 | 5,087.05 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 5,207.60 | 4,996.20 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 4,599.20 | 4,590.30 |
| 12 May 2026 | Quarterly Result Announcement | NA | 12 May 2026 | 4,683.70 | 4,875.40 |
| 17 Jul 2026 | Dividend | ₹ 75.00 /share | 17 Jul 2026 | 4,875.40 | 4,697.80 |
| 28 Jul 2026 | Annual General Meeting | NA | 28 Jul 2026 | 4,875.40 | 4,690.15 |
| 28 Jul 2026 | Quarterly Result Announcement | NA | 28 Jul 2026 | 4,568.40 | 4,690.15 |
Announcements
Shareholder Meeting / Postal Ballot-Scrutinizers Report2 days ago
2 days agoShareholder Meeting / Postal Ballot-Outcome of AGM3 days ago
3 days agoBoard Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2026.3 days ago
3 days agoAnnouncement under Regulation 30 (LODR)-Change in Directorate4 days ago
4 days agoBoard Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30 2026.Jul 20, 2026
Jul 20, 2026Response To Clarification Sought By BSE Limited.
Jul 17, 2026
Jul 17, 2026Clarification sought from Pfizer LtdJul 17, 2026
Jul 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 10, 2026
Jul 10, 2026Letter To Shareholders Providing The Weblink To Access The Annual Report For Financial Year 2025-26.
Jul 07, 2026
Jul 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 07, 2026
Jul 07, 2026Shareholders Meeting - AGM NoticeJul 06, 2026
Jul 06, 2026Reg. 34 (1) Annual Report.Jul 06, 2026
Jul 06, 2026Closure of Trading WindowJun 26, 2026
Jun 26, 2026Newspaper AdvertisementJun 04, 2026
Jun 04, 2026Newspaper AdvertisementJun 03, 2026
Jun 03, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMay 12, 2026
May 12, 2026Intimation Of Date Of Annual General MeetingMay 12, 2026
May 12, 2026Intimation Of Record DateMay 12, 2026
May 12, 2026Corporate Action-Board approves DividendMay 12, 2026
May 12, 2026Audited Financial Results For The Financial Year
Ended March 31 2026.May 12, 2026
May 12, 2026Board Meeting Outcome for Outcome Of Board Meeting Held On May 12 2026May 12, 2026
May 12, 2026Board Meeting Intimation for Board Meeting To Consider And Approve The Financial Results For The Quarter And Year Ended March 31 2026.May 05, 2026
May 05, 2026Intimation Pursuant To Regulation 30 Of SEBI LODR Regulations 2015Apr 24, 2026
Apr 24, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 09, 2026
Apr 09, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 08, 2026
Apr 08, 2026Announcement under Regulation 30 (LODR)-Change in ManagementMar 31, 2026
Mar 31, 2026Closure of Trading WindowMar 28, 2026
Mar 28, 2026Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And
Nine Months Ended December 31 2025.Feb 09, 2026
Feb 09, 2026Newspaper AdvertisementFeb 05, 2026
Feb 05, 2026Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.Jan 30, 2026
Jan 30, 2026Announcement under Regulation 30 (LODR)-Change in ManagementJan 20, 2026
Jan 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2026
Jan 09, 2026Closure of Trading WindowDec 29, 2025
Dec 29, 2025Disclosure under Regulation 30A of LODRDec 28, 2025
Dec 28, 2025Intimation Pursuant To Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Dec 24, 2025
Dec 24, 2025Announcement under Regulation 30 (LODR)-Change in ManagementDec 23, 2025
Dec 23, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 19, 2025
Dec 19, 2025Exclusive Supply And Marketing Agreement With Cipla Limited For Certain Products.Dec 19, 2025
Dec 19, 2025Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter And Half Year
Ended September 30 2025Nov 12, 2025
Nov 12, 2025Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 03, 2025
Nov 03, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 08, 2025
Oct 08, 2025Closure of Trading WindowSep 29, 2025
Sep 29, 2025Board Meeting Outcome for Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2025 Held Today August 13 2025Aug 13, 2025
Aug 13, 2025Outcome Of Board Meeting - Unaudited Financial Results For The Quarter Ended June 30 2025 Held Today August 13 2025Aug 13, 2025
Aug 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 11, 2025
Aug 11, 2025Launch Of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P. 20 - Valent (PCV20)Aug 11, 2025
Aug 11, 2025Board Meeting Intimation for Board Meeting To Consider And Approve The Unaudited Financial Results For The Quarter Ended June 30 2025Aug 07, 2025
Aug 07, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 22, 2025
Jul 22, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 21, 2025
Jul 21, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 64.77
ATR(14)
Less Volatile 104.14
STOCH(9,6)
Neutral 68.92
STOCH RSI(14)
Overbought 84.80
MACD(12,26)
Bullish 16.39
ADX(14)
Weak Trend 15.81
UO(9)
Bearish 59.87
ROC(12)
Uptrend And Accelerating 2.93
WillR(14)
Overbought -11.34
About Pfizer
Pfizer Limited is an Indian pharmaceutical company engaged in manufacturing, marketing, trading, and exporting pharmaceutical products. It has a manufacturing facility in Goa and works with contract manufacturers across India. The company offers a diverse portfolio of products including vaccines, anti-infectives, cardiac medications, pain relief, maternal nutrition, gastrointestinal treatments, contraceptives,...more
Website
Chairperson NamePradip Shah
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
